Select Medical (SEM) shares jumped 8.4% following the announcement of a definitive agreement to take the company private. The transaction is priced at $16.50 per share, triggering an immediate rally as the market aligned with the offer price. However, analysts at Zacks have suggested that the offer may undervalue the healthcare provider relative to its long-term potential. This sentiment stems from previous price targets that were significantly higher than the current $16.50 bid. The discrepancy between the offer and analyst valuations has sparked discussions regarding the possibility of a higher counter-offer or price renegotiation. Investors are closely monitoring the deal's progression, as take-private transactions in the healthcare sector often face rigorous valuation scrutiny.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis